NCT02212613View on ClinicalTrials.gov

Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Major Depressive Disorder and Irritability
Interventions
DRUG

Brexpiprazole

Treatment (6 weeks) Up to 2 mg/day, once daily dose, tablets, orally

Trial Locations (1)

30329

Emory University, Atlanta

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY